标题
Targeting A3 and A2A adenosine receptors in the fight against cancer
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 23, Issue 8, Pages 669-678
出版商
Informa UK Limited
发表日期
2019-06-13
DOI
10.1080/14728222.2019.1630380
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting the A3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
- (2019) Shira Cohen et al. Drug Design Development and Therapy
- Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway
- (2019) Ali Masjedi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
- (2018) Robert D. Leone et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A2A adenosine receptor agonists and their potential therapeutic applications. An update
- (2018) Angel Guerrero CURRENT MEDICINAL CHEMISTRY
- Adenosine signaling and the immune system: When a lot could be too much
- (2018) Luca Antonioli et al. IMMUNOLOGY LETTERS
- A2AAdenosine Receptor Gene Deletion or Synthetic A2AAntagonist Liberate Tumor-Reactive CD8+T Cells from Tumor-Induced Immunosuppression
- (2018) Jorgen Kjaergaard et al. JOURNAL OF IMMUNOLOGY
- Pharmacology of Adenosine Receptors: The State of the Art
- (2018) Pier Andrea Borea et al. PHYSIOLOGICAL REVIEWS
- Current status and future directions of cancer immunotherapy
- (2018) Hongming Zhang et al. Journal of Cancer
- Targeting adenosine for cancer immunotherapy
- (2018) Robert D. Leone et al. Journal for ImmunoTherapy of Cancer
- Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives
- (2018) Anvar Soleimani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting adenosine A2A receptor antagonism for treatment of cancer
- (2018) Miles Congreve et al. Expert Opinion on Drug Discovery
- Targeting A2 adenosine receptors in cancer
- (2017) David Allard et al. IMMUNOLOGY AND CELL BIOLOGY
- Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer
- (2017) Mohammad H. Kazemi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
- (2017) Si-Rui Ma et al. Molecular Cancer
- A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
- (2017) Melanie Mediavilla-Varela et al. NEOPLASIA
- CD73–adenosine: a next-generation target in immuno-oncology
- (2016) David Allard et al. Immunotherapy
- Adenosine and the adenosine A2A receptor agonist, CGS21680, upregulate CD39 and CD73 expression through E2F-1 and CREB in regulatory T cells isolated from septic mice
- (2016) Rui Bao et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Current and experimental treatments of Parkinson disease: A guide for neuroscientists
- (2016) Wolfgang Oertel et al. JOURNAL OF NEUROCHEMISTRY
- Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
- (2016) Pier Andrea Borea et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
- (2016) Akio Ohta Frontiers in Immunology
- Immunological mechanisms of the antitumor effects of supplemental oxygenation
- (2015) Stephen M. Hatfield et al. Science Translational Medicine
- Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses
- (2015) Paul A. Beavis et al. Cancer Immunology Research
- Adenosine A3 Receptor Suppresses Prostate Cancer Metastasis by Inhibiting NADPH Oxidase Activity
- (2015) Sarvesh Jajoo et al. NEOPLASIA
- NF-κB enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A2A receptors
- (2014) Laurie Bruzzese et al. CELLULAR SIGNALLING
- Adenosine and inflammation: what's new on the horizon?
- (2014) Luca Antonioli et al. DRUG DISCOVERY TODAY
- Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer
- (2014) Bertrand Allard et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Immunoregulatory activity of adenosine and its role in human cancer progression
- (2014) Sylvia Muller-Haegele et al. Expert Review of Clinical Immunology
- Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
- (2014) Stephen M. Hatfield et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Antagonism of adenosine A2A receptor expressed by lung adenocarcinoma tumor cells and cancer associated fibroblasts inhibits their growth
- (2013) Melanie Mediavilla-Varela et al. CANCER BIOLOGY & THERAPY
- Treatment of motor fluctuations in Parkinson’s disease: recent developments and future directions
- (2013) Adolfo Ramirez-Zamora et al. Expert Review of Neurotherapeutics
- CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study
- (2013) S. M. Stemmer et al. ONCOLOGIST
- CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer
- (2013) S. Loi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The stimulation of A3 adenosine receptors reduces bone-residing breast cancer in a rat preclinical model
- (2012) Katia Varani et al. EUROPEAN JOURNAL OF CANCER
- The Anti-Tumor Effect of A3 Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells
- (2012) Fabrizio Vincenzi et al. PLoS One
- Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice
- (2012) Antonella Montinaro et al. PLoS One
- Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells
- (2011) Michael Romio et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pharmacological and therapeutic effects of A3 adenosine receptor agonists
- (2011) Pnina Fishman et al. DRUG DISCOVERY TODAY
- Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway
- (2011) Mahmoud Aghaei et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A3Receptors Are Overexpressed in Pleura from Patients with Mesothelioma and Reduce Cell Growth via Akt/Nuclear Factor-κB Pathway
- (2010) Katia Varani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors
- (2010) Stefania Gessi et al. BIOCHEMICAL PHARMACOLOGY
- Adenosine receptors and cancer
- (2010) Stefania Gessi et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation
- (2010) Silvana Morello et al. CANCER BIOLOGY & THERAPY
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver
- (2010) S. Cohen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immunotherapy of cancer
- (2009) Hossein Borghaei et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cl-IB-MECA enhances TRAIL-induced apoptosis via the modulation of NF-κB signalling pathway in thyroid cancer cells
- (2009) Silvana Morello et al. JOURNAL OF CELLULAR PHYSIOLOGY
- T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
- (2009) Michail V. Sitkovsky TRENDS IN IMMUNOLOGY
- Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
- (2008) M. V. Sitkovsky et al. CLINICAL CANCER RESEARCH
- The A3 adenosine receptor: An enigmatic player in cell biology
- (2007) Stefania Gessi et al. PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started